Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Ergo-Health LLC has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are spread across 2 distinct examiners and 2 distinct art units, showing a diversified prosecution landscape compared to more concentrated portfolios. This spread indicates that the company's intellectual property covers multiple sub-sectors within the biotechnology field, requiring a comprehensive management approach to address different technical requirements.
BELL, SARA ELIZABETH is the busiest examiner with 1 busiest examiner pending action. Given the total of 2 pending office actions, the workload is evenly distributed among the 2 distinct examiners. This arrangement may require coordinating legal strategies across different administrative sections of the patent office, as the 2 distinct art units may have varying internal guidelines. The presence of multiple units suggests that the company's technology may bridge different scientific disciplines, requiring a versatile legal strategy to address the unique concerns of each unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BELL, SARA ELIZABETH | 1 | 68.8% | +38.2% |
| HASTINGS, ALISON AZAR | 1 | 63.5% | +40.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18437501 | METHODS FOR EXTENDING THE LIFESPAN OF CELLS AND ORGANISMS | BELL, SARA ELIZABETH | — |
| 17904977 | Method of Treating Diseases | HASTINGS, ALISON AZAR | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18437501 | METHODS FOR EXTENDING THE LIFESPAN OF CELLS AND ORGANISMS | BELL, SARA ELIZABETH | 1625 | §102§103§112DP | Non-Final OA | — | Pending | Feb 09, 2024 |
| 17904977 | Method of Treating Diseases | HASTINGS, ALISON AZAR | 1627 | §103 | Final Rejection | — | Pending | Aug 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial